Barth Syndrome: Psychosocial Impact and Quality of Life Assessment

Author:

Bath AnandbirORCID,Akbilgic Oguz,Wilbanks DavidORCID,Patel Jay,Wallen Morgan,Haji ShereenORCID,Das Arnab,Alexander JohnORCID,Pour-Ghaz Issa,Alkhatib DeyaORCID,Huang YonglinORCID,Lontok ErikORCID,Jefferies John

Abstract

Background: Barth syndrome (BTHS) is a rare X-linked genetic disease that affects multiple systems and leads to complex clinical manifestations. Although a considerable amount of research has focused on the physical aspects of the disease, less has focused on the psychosocial impact and quality of life (QoL) in BTHS. Methods: The current study investigated caregiver- (n = 10) and self-reported (n = 16) psychological well-being and QoL in a cohort of BTHS-affected patients and families. Participants completed the depression and anxiety components of the Patient-Reported Outcomes Information System (PROMIS) Short Form 8A and Health-related quality of life (HRQoL) surveys at enrollment and again during a follow-up period ranging from 6 to 36 months after baseline. Results: Quality of life changed significantly over time and the various domains with some improvement and some decline. Among the available caregiver-patient dyad data, there was a trend toward discordance between caregiver and self-reported outcomes. Most notably, patients reported improvement in HRQoL, while caregivers reported declines. This suggests that there may be differences in perceived quality of life between the patients and parents, though our study is limited by small sample size. Conclusion: Our study provides valuable insights into the impacts of psychosocial and mental health aspects of BTHS. Implications of these findings include incorporating longitudinal assessment of QoL and screening for psychological symptoms in BTHS care to identify interventions that may drastically impact health status and the course of the disease.

Funder

Barth Syndrome Foundation and Barth Syndrome UK/Barth Syndrome Trust

Publisher

MDPI AG

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Reference28 articles.

1. (2022, October 09). Barth Syndrome Foundation the Externally-Led Patient-Focused Drug Development Meeting. Available online: https://fda.report/media/130562/EL-PFDD+Meeting+on+Barth+Syndrome+Voice+of+the+Patient+Report.pdf.

2. Barth syndrome;Jefferies;Am. J. Med. Genet. Part C Semin. Med. Genet.,2013

3. An X-Linked Recessive Cardiomyopathy with Abnormal Mitochondria;Neustein;Pediatrics,1979

4. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes;Barth;J. Neurol. Sci.,1983

5. A novel X-linked gene, G4.5. is responsible for Barth syndrome;Bione;Nat. Genet.,1996

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3